Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analogs, formulations and derivatives of imatinib: a patent review.
Musumeci F, Schenone S, Grossi G, Brullo C, Sanna M. Musumeci F, et al. Among authors: schenone s. Expert Opin Ther Pat. 2015;25(12):1411-21. doi: 10.1517/13543776.2015.1089233. Epub 2015 Sep 15. Expert Opin Ther Pat. 2015. PMID: 26372795 Review.
Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors.
Musumeci F, Sanna M, Grossi G, Brullo C, Fallacara AL, Schenone S. Musumeci F, et al. Among authors: schenone s. Curr Med Chem. 2017;24(19):2059-2085. doi: 10.2174/0929867324666170303162100. Curr Med Chem. 2017. PMID: 28266267 Review.
An Update on JAK Inhibitors.
Musumeci F, Greco C, Giacchello I, Fallacara AL, Ibrahim MM, Grossi G, Brullo C, Schenone S. Musumeci F, et al. Among authors: schenone s. Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502. Curr Med Chem. 2019. PMID: 29589523 Review.
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
Molinari A, Fallacara AL, Di Maria S, Zamperini C, Poggialini F, Musumeci F, Schenone S, Angelucci A, Colapietro A, Crespan E, Kissova M, Maga G, Botta M. Molinari A, et al. Among authors: schenone s. Bioorg Med Chem Lett. 2018 Nov 15;28(21):3454-3457. doi: 10.1016/j.bmcl.2018.09.024. Epub 2018 Sep 20. Bioorg Med Chem Lett. 2018. PMID: 30262428
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
Fallacara AL, Passannanti R, Mori M, Iovenitti G, Musumeci F, Greco C, Crespan E, Kissova M, Maga G, Tarantelli C, Spriano F, Gaudio E, Bertoni F, Botta M, Schenone S. Fallacara AL, et al. Among authors: schenone s. Eur J Med Chem. 2019 Nov 1;181:111545. doi: 10.1016/j.ejmech.2019.07.048. Epub 2019 Jul 18. Eur J Med Chem. 2019. PMID: 31400706
213 results